Apoptosis Antagonizing Transcription Factor (AATF) (C-Term) Peptide
AATF
Reactivity: Human
BP
Sodium azide
-
- Target See all AATF products
- AATF (Apoptosis Antagonizing Transcription Factor (AATF))
- Protein Region
- C-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
12 amino acids near the carboxy terminus of human AATF.
Human
-
-
- Application Notes
- AATF peptide is used for blocking the activity of AATF.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- AATF (Apoptosis Antagonizing Transcription Factor (AATF))
- Synonyms
- AATF Peptide, ded Peptide, che1 Peptide, che-1 Peptide, cb109 Peptide, sb:cb109 Peptide, wu:fc13d05 Peptide, zgc:162071 Peptide, CHE-1 Peptide, CHE1 Peptide, DED Peptide, 4933415H02Rik Peptide, 5830465M17Rik Peptide, Che-1 Peptide, Trb Peptide, Ded Peptide, apoptosis antagonizing transcription factor Peptide, Apoptosis antagonizing transcription factor Peptide, apoptosis antagonizing transcription factor S homeolog Peptide, AATF Peptide, aatf Peptide, BFR2 Peptide, NAEGRDRAFT_56916 Peptide, Aatf Peptide, aatf.S Peptide
-
You are here:
